← Back to Patent Explorer
US4046877A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of increasing immunologic competence

Assignee: Syntex USA LLC
•
Filing: 1976-02-17
•
Granted: 1977-09-06
•
Expires: 1996-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Human serum prealbumin is shown to possess thymus hormone-like properties of increasing immunologic competence. Pharmaceutical compositions containing this material, useful for increasing immunologic competence, are described.

Inventors

  • 👤 Abraham White
  • 👤 Pamela M. Burton

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 05:38
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/76; C07K14/765; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83; Y10S530/831

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 25 words
A pharmaceutical composition useful for increasing immunologic competence comprising a therapeutically effective amount of human serum prealbumin in admixture with a pharmaceutically acceptable non-toxic carrier.
Claim 2
Dependent Claim 25 words
A pharmaceutical composition useful for increasing immunologic competence comprising a therapeutically effective amount of human serum prealbumin in admixture with a pharmaceutically acceptable non-toxic carrier.
Claim 3
Independent Claim 35 words
A method of increasing immunologic competence in a subject in need of such treatment which method comprises administering to said subject a therapeutically effective amount of human serum prealbumin or a pharmaceutical composition containing same.
Claim 4
Independent Claim 35 words
A method of increasing immunologic competence in a subject in need of such treatment which method comprises administering to said subject a therapeutically effective amount of human serum prealbumin or a pharmaceutical composition containing same.
Claim 5
Dependent Claim 21 words
The method of claim 2 wherein human serum prealbumin is administered in an amount between about 10 pg. and 20 μg/kg/day.

References Cited (Backward Citations)

CA647931A Cited
US3560475A Cited
US3850903A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-09-05 1981-03-07 1981-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-09-05 1985-03-07 1985-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-09-05 1989-03-07 1989-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag